Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
- Recent U.S. $150 Million funding round lead by a syndicate of leading biopharmaceutical institutional investors supports advancement of clinical-stage programs CYB003 and CYB004 - - Received U.S....